Royalty Pharma has acquired a royalty interest in Amgen's Imdelltra, an innovative BiTE antibody for the treatment of small cell lung cancer, from BeOne Medicines for an upfro...
Continue reading
We are delightet that IAM has recognized eight of our partners as Strategy 300 Global Leaders 2025:
Continue reading
Maiwald has once again been listed in this year's IP Star Awards by IP Stars by Managing IP (MIP). The IP Stars are experienced practitioners who have been recommended or iden...
Continue reading
For more awards and information, click here.
